Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

Abstract

Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1,2,3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anti-coagulant and anti-inflammatory effects1,2,3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: APC has anti-apoptotic activity in hypoxic human BECs.
Figure 2: APC blocks p53-dependent apoptosis in hypoxic human BECs.
Figure 3: In vivo neuroprotective effects of recombinant mouse APC during focal ischemic stroke in mice requires EPCR and PAR-1.

Similar content being viewed by others

References

  1. Griffin, J.H., Zlokovic, B. & Fernandez, J.A. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin. Hematol. 39, 197–205 (2002).

    Article  CAS  Google Scholar 

  2. Griffin, J.H. Blood coagulation. The thrombin paradox. Nature 378, 337–338 (1995).

    Article  CAS  Google Scholar 

  3. Esmon, C.T. et al. Endothelial protein C receptor. Thromb. Haemost. 82, 251–258 (1999).

    Article  CAS  Google Scholar 

  4. Mizutani, A., Okajima, K., Uchiba, M. & Noguchi, T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95, 3781–3787 (2000).

    CAS  PubMed  Google Scholar 

  5. Shibata, M. et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103, 1799–1805 (2001).

    Article  CAS  Google Scholar 

  6. Bernard, G.R. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699–709 (2001).

    Article  CAS  Google Scholar 

  7. Folsom, A.R. et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100, 736–742 (1999).

    Article  CAS  Google Scholar 

  8. Joyce, D.E. et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 276, 11199–11203 (2001).

    Article  CAS  Google Scholar 

  9. Riewald, M. et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880–1882 (2002).

    Article  CAS  Google Scholar 

  10. Castellino, F.J. et al. Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb. Haemost. 88, 462–472 (2002).

    Article  CAS  Google Scholar 

  11. Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031–36034 (1999).

    Article  CAS  Google Scholar 

  12. Carr, A.M. Cell cycle. Piecing together the p53 puzzle. Science 287, 1765–1766 (2000).

    Article  CAS  Google Scholar 

  13. Ogawara, Y. et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 277, 21843–21850 (2002).

    Article  CAS  Google Scholar 

  14. Stempien-Otero, A. et al. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J. Biol. Chem. 274, 8039–8045 (1999).

    Article  CAS  Google Scholar 

  15. Kimura, M. et al. Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J. Biol. Chem. 276, 26453–26460 (2001).

    Article  CAS  Google Scholar 

  16. Zhu, Y. et al. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons. J. Biol. Chem. 277, 22909–22914 (2002).

    Article  CAS  Google Scholar 

  17. Gale, A.J., Sun, X., Heeb, M.J. & Griffin, J.H. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Protein Sci. 6, 132–140 (1997).

    Article  CAS  Google Scholar 

  18. Ye, X. et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochem. Biophys. Res. Commun. 259, 671–677 (1999).

    Article  CAS  Google Scholar 

  19. Vaughan, P.J, Pike, C.J, Cotman, C.W & Cunningham, D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389–5401 (1995).

    Article  CAS  Google Scholar 

  20. Striggow, F. et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. USA 97, 2264–2269 (2000).

    Article  CAS  Google Scholar 

  21. Turgeon, V.L. et al. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 6882–6891 (1998).

    Article  CAS  Google Scholar 

  22. Donovan, F.M & Cunningham, D.D. Signaling pathways involved in thrombin-induced cell protection. J. Biol. Chem. 273, 12746–12752 (1998).

    Article  CAS  Google Scholar 

  23. Miyashita, T. & Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293–299 (1995).

    Article  CAS  Google Scholar 

  24. Yamamoto, K. et al. Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells. Hypertension 37, 1341–1348 (2001).

    Article  CAS  Google Scholar 

  25. Faleiro, L. & Lazebnik, Y. Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 151, 951–959 (2000).

    Article  CAS  Google Scholar 

  26. Ackermann, E.J., Taylor, J.K., Narayana, R. & Bennett, C.F. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274, 11245–11252 (1999).

    Article  CAS  Google Scholar 

  27. Hoffmann, A., Gloe, T. & Pohl, U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell. Physiol. 188, 33–44 (2001).

    Article  CAS  Google Scholar 

  28. Wang, Y.F. et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228–231 (1998).

    Article  CAS  Google Scholar 

  29. Flavin, M.P., Zhao, G. & Ho, L.T. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29, 347–354 (2000).

    Article  CAS  Google Scholar 

  30. Heeb, M.J et al. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb. Res. 52, 33–43 (1988).

    Article  CAS  Google Scholar 

  31. Mackic, J.B. et al. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734–743 (1998).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by US National Institutes of Health grant HL63290 and HL52246.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Berislav V. Zlokovic.

Ethics declarations

Competing interests

B.V.Z. has a financial relationship with Socratech, LLC, relative to his service in the capacity of Scientific Program Director. He receives consultation compensation, stock ownership and other equity interest. The relationship includes patent applications and may include trademarks, copyrights and/or licensing agreements. J.H.G. has a financial relationship with Socratech, LLC, as a member of their Scientific Advisory Board, with similar compensations and inclusions.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, T., Liu, D., Griffin, J. et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9, 338–342 (2003). https://doi.org/10.1038/nm826

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm826

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing